Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8987420 High affinity human antibodies to human angiopoietin-2

Patent 8987420 was granted and assigned to Regeneron Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024562 Antibody binding to Tie2 and use thereof
0
Edits on 17 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11958910 Bispecific antigen binding molecules that bind HER2, and methods of use thereof
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+418 characters)
Article

Patent abstract

The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.

Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher Daly0
Gavin Thurston0
Edits on 25 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08987420 High affinity human antibodies to human angiopoietin-2 US Patent 8987420 High affinity human antibodies to human angiopoietin-2

Infobox
Patent Number
08987420
Patent Number
8987420
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=08987420
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08987420
Edits on 29 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 29 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08987420 High affinity human antibodies to human angiopoietin-2

Infobox
Is a
Patent
Patent
Current assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08987420
Date of patent
March 24, 2015
Patent application number
12843905
Date Filed
July 27, 2010
Patent primary examiner
‌
Claire Kaufman

Find more entities like US Patent 8987420 High affinity human antibodies to human angiopoietin-2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo